Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
UTI-lizer logo — Revolutionizes the Urinary Tract Infection diagnostics!

UTI-lizer

Revolutionizes the Urinary Tract Infection diagnostics!

Founded 2021 Sweden Sweden 10 employees Seed Total: $7.00M Biotechnology, Medical Devices

General Information

Company Name UTI-lizer
Founded Year 2021
Location Sweden Sweden
Employees 10
Industries Biotechnology, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with UTI-lizer. To contact UTI-lizer, visit utilizer.se.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does UTI-lizer compare?

A PDF of UTI-lizer and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting UTI-lizer soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About UTI-lizer

UTI-lizer is a biotechnology startup revolutionizing urinary tract infection diagnostics. With the slogan "Revolutionizes the Urinary Tract Infection diagnostics!" the company addresses the issue of UTIs being the most common bacterial infections in women, with current over-the-counter tests not being sensitive enough. Founded in 2021 and headquartered in Sweden, the company secured a kr7.00MSeed Round investment on 17 May 2023 with investors including Almi Invest and Sting. The company's novel approach involves miniaturizing culture-based bacterial detection in a dipstick format with a highly sensitive and quantitative digital bioassay, enabling the detection and quantification of bacteria in the clinically relevant range. This can be achieved without the need for complicated lab instruments, with a readout accessible by the naked eye or a simple cell phone camera. UTI-lizer's diagnostic test stands out due to its ability to empower non-trained operators to detect urinary tract infections in the clinically relevant range in a home setting, promising a significant impact on UTI diagnostics and treatment.

Business keywords: Urinary Tract Infections, UTI diagnostics, Bacterial detection, Diagnostic test, Home testing, Point-of-care technology, Healthcare innovation, Medical technology, Bioassay, Digital healthcare, Women's health, Antibiotic stewardship

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Uti kr7.00M 2
Almi Invest
Almi Invest, Propel Capital
17 May 2023
Non Equity Assistance Uti Undisclosed 1
Sting
Sting
09 Sep 2022

UTI-lizer Alternatives & Competitors

View All Alternatives
UTI-lizer vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
UTI-lizer vs
DxUpClose, Inc.
DxUpClose, Inc. United States

Delivering rapid antibiotic sensitivity results directly to healthcare professionals, ensuring optim...

Series A
1 employees
Biotechnology, Health Care
UTI-lizer vs
Kite Medical
Kite Medical Ireland

Kite Medical created a non-invasive device to detect kidney reflux in children, improving patient ex...

Convertible Note
2-10 employees
Biotechnology, Health Care
View all alternatives

FAQ About UTI-lizer

Revolutionizes the Urinary Tract Infection diagnostics!
UTI-lizer was founded in 2021.
UTI-lizer is headquartered in Sweden.
UTI-lizer operates in Biotechnology and Medical Devices. Its work centres on Urinary Tract Infections, UTI diagnostics, Bacterial detection and Diagnostic test.
UTI-lizer has approximately 10 employees.
UTI-lizer has completed 2 funding rounds, raising a total of $7.00M. The latest funding stage is Seed.
Top alternatives and competitors to UTI-lizer include EMPE Diagnostics, DxUpClose, Inc., Kite Medical, PSM Inc., Truvian. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
UTI-lizer and EMPE Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for UTI-lizer, https://bouncewatch.com/company/uti-lizer, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout